3140748
Last Update Posted: 2023-09-06
Recruiting has ended
All Genders accepted | 18 Years + |
70 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Kinetics of Serum β-D-glucan During Peritonitis With Candida in Resuscitation
Intraabdominal fungal infections with Candida are constantly increasing. Their diagnosis and treatment is difficult. Morbidity and mortality are high. Β-D-Glucan has been proposed as a marker of systemic fungal infection in candidemia. Moreover, its kinetics is associated with therapeutic success. On the other hand, there are no data on intraabdominal infections that are much more frequent. The objective of the study is to evaluate the initial levels of β-D-glucan and its daily kinetics during the treatment of fungal peritonitis in resuscitation compared to a control group with a yeast-free peritonitis.
Eligibility
Relevant conditions:
Peritonitis Infectious
Candida Infection
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
Inclusion criteria
Exclusion criteria
locations
Contact Information
Overall Contact
No valid contacts available
Data sourced from ClinicalTrials.gov